Potential Neuropathic Pain Treatment Shows Promise in Preclinical Tests, Newsroom

A non-opioid designer molecule for treating chronic neuropathic pain by calming hyperactive pain-sensing neurons in the peripheral nervous system has had promising results in a preclinical study.

Full article: Neuropathic pain: preclinical and early clinical

Future cancer research priorities in the USA: a Lancet Oncology

Potential Neuropathic Pain Treatment Shows Promise in Preclinical

Evolving Cardiac Electrical Therapies for Advanced Heart Failure

Larry Schlossman

Mind the gap: A survey of how cancer drug carriers are susceptible

Targeting nociceptive transient receptor potential channels to

First-in-Human Experience and Acute Procedural Outcomes Using a

Neurotheranostics as personalized medicines - ScienceDirect

Akelos

Potential neuropathic pain treatment shows promise in Preclinical

Cells, Free Full-Text

Targeting nociceptive transient receptor potential channels to

The endocannabinoid system – current implications for drug

Dry Eye